Dr. Gleave to give MSFHR-VCHRI lecture on the PC-TRiADD Model

Date Posted: 
2014-01-09

The Michael Smith Foundation for Health Research (MSFHR) and the Vancouver Coastal Research Institute are pleased to present a lecture by one of British Columbia’s most innovative scientists — a man who has bridged the gap between clinical research and new commercial treatments for disease.

Dr. Martin Gleave is the most recent recipient of the MSFHR Aubrey J. Tingle Prize, given to a British Columbia clinician scientist or scholar practitioner whose work in health research is internationally recognized and has significant impact on advancing clinical or health services and policy research — as well as its uptake — to improve health and the health system in BC and globally.

Please join Dr. Diane Finegood, MSFHR president and CEO, as she presents Dr. Gleave with his award. Dr. Gleave will also deliver a lecture and take questions from the audience.

Title:  Bridging the Mind to Market Gap in Translational Cancer Research: The Vancouver PC-TRiADD Model

Presenter:  Dr. Martin Gleave MD, FRCSC, FACS

Date:  Tuesday, January 14, 2014

Time:  4 – 5 p.m. (presentation and lecture); 5 – 6 p.m. (reception)

Location: Paetzold Auditorium & Atrium, 1st Floor, Jim Pattison Pavilion, Vancouver General Hospital, 855 West 12th Avenue

Dr. Martin Gleave is executive director of the Vancouver Prostate Centre, chief executive officer of PC-TRIADD, and a distinguished professor in the department of urologic sciences at UBC. His major research focus involves the study of cellular and molecular mechanisms mediating progression of prostate cancer to its lethal stage of androgen independence, and use of this information to develop integrated multimodality therapies that specifically target these mechanisms. He is the scientific founder of OncoGenex Pharmaceuticals Inc.

The Michael Smith Foundation for Health Research harnesses the power of health research to improve the health of British Columbians and their health system. It does this by building BC’s capacity for world-class research by funding the best scientists; coordinating the sharing of health research resources across the province; and bringing people together for health research planning and action. Learn more at www.msfhr.org.

Vancouver Coastal Health Research Institute (VCHRI) is the research body of Vancouver Coastal Health. VCHRI includes three of BC’s largest academic and teaching health sciences centres — Vancouver General Hospital, UBC Hospital, and GF Strong Rehabilitation Centre — as well as many other hospitals and public health agencies across Vancouver Coastal Health. VCHRI is academically affiliated with the UBC Faculty of Medicine and is one of Canada’s top funded research centres receiving between $80 and $100 million in research funding annually.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Robbie Burns celebration

Robbie Burns Gala at the Pan Pacific Vancouver: January 25

The Pan Pacific Vancouver is hosting a celebration of Scotland's most famous poet, Robbie Burns, on January 25.  The event will include fundraising for Prostate Cancer Canada's Plaid for Dad campaign. There will be a traditional itinerary, starting with the official piping in of the guests, with exclusive malt tastings, authentic Scottish cuisine celebrating the haggis and ending the evening with a chorus of Auld Lang Syne. Click here for more information and tickets.

It's a Snow Day poster

It's A Snow Day at Mt. Seymour: March 9

Mt. Seymour is hosting It's A Snow Day, a fundraiser for Prostate Cancer Foundation BC, on Friday March 9. The event will include slope time, a reception, and a silent auction. Click here for more details including how to register, donate and/or sponsor.

 

 

Employment

Work at the Vancouver Prostate Centre

Monday, January 30, 2017

Dr. Amina Zoubeidi leads identification of gene linked to growth of aggressive neuroendocrine prostate cancer (NEPC)

DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.